biomanufacturing
Thermo Fisher to Repurchase $2B of its Shares, Acquire BD's Advanced Bioprocessing Business
The BD business, which has annual revenues of about $100 million, offers technical services as well as peptones for cell culture media used in biopharmaceutical applications.
Horizon Discovery Licenses CRISPR for Use in Cell Lines for Biomanufacturing
The firm has secured rights to use CRISPR in cell lines for biomanufacturing and will work with Solentim to increase editing throughput while decreasing costs.
Millipore claims that its test, which incorporates transcription-mediated amplification technology developed by Gen-Probe offshoot Roka Bioscience, provides a few advantages over PCR-based Mycoplasma testing.
PGx & molecular Dx
The approximately $17 million acquisition, announced last week, will have "no impact" on Clinical Data's focus as a pharmacogenomics company, according to CEO Drew Fromkin.
Apr 6, 2009
Mar 16, 2009